At its July 2025 meeting, the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) recommended granting marketing authorization in the European Union for Romvimza ...

First regulatory approval in the world for pimicotinib based on positive data from global Phase 3 MANEUVER study In MANEUVER, pimicotinib significantly improved objective response rate at week 25 (54% ...

Germany-headquartered science and technology giant Merck announced that pimicotinib, a colony-stimulating factor-1 receptor ...

Doctor Min Li from West China Hospital, one of the country's largest centers for TGCT management, explained that CSF-1R ...

Circulating tumor cells were first described in 1869 by Thomas Ashworth, an Australian pathologist who observed them in a peripheral blood sample taken from a patient with metastatic cancer. 1 They ...

A counterintuitive discovery published today is reshaping how scientists think about one of cancer's most common genomic events: when a cell accidentally duplicates its entire DNA supply and fails to ...

Chimeric antigen receptor T-cell therapy—CAR T for short—has been a major advance in treating blood cancers like leukemia and lymphoma. But the immunotherapy has struggled against solid tumors for two ...

Significant advances have been made in the development of patient-derived tumor "organoids" for preclinical research in two ...